COVID-19 pandemic
South Korea signs an agreement with Novavax and Pfizer to secure additional doses of the COVID-19 vaccine for 23 million people in the second quarter of this year.
Sources: Yonhap News Agency
Changes
- South Korea signs a agreement with Novavax and Pfizer to secure additional doses of vaccine for 23 million people in second quarter.
- South Korea signs an agreement with Novavax and Pfizer to secure additional doses of the COVID-19 vaccine for 23 million people in the second quarter of this year.